Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
17%
Ph phase_2
2
33%
Ph phase_4
3
50%

Phase Distribution

0

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(2)
Other(2)

Detailed Status

unknown2
Completed2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (33.3%)
Phase 31 (16.7%)
Phase 43 (50.0%)

Trials by Status

unknown233%
completed233%
recruiting233%

Recent Activity

2 active trials
Showing 5 of 6
recruitingphase_4

Effect of Acetylcysteine Inhalation on Incidence and Time to Develop Ventilator Associated Pneumonia in Critically Ill Mechanically Ventilated Patients

NCT07409727
recruitingphase_2

Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial

NCT07364747
completedphase_2

N-Acetylcysteine Protection Against Radiation Induced Cellular Damage

NCT04154982
unknownphase_3

Using Acetylcysteine and Vitamin E With Psoriasis Vulgaris

NCT05906498
unknownphase_4

Effect of High-Dose NAC on Patients With DPN

NCT04766450
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07409727Phase 4

Effect of Acetylcysteine Inhalation on Incidence and Time to Develop Ventilator Associated Pneumonia in Critically Ill Mechanically Ventilated Patients

Recruiting
NCT07364747Phase 2

Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial

Recruiting
NCT04154982Phase 2

N-Acetylcysteine Protection Against Radiation Induced Cellular Damage

Completed
NCT05906498Phase 3

Using Acetylcysteine and Vitamin E With Psoriasis Vulgaris

Unknown
NCT04766450Phase 4

Effect of High-Dose NAC on Patients With DPN

Unknown
NCT03354572Phase 4

Pilot Study: Postoperative Pain Reduction by Pre Emptive N-Acetylcysteine

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6